SCHEMBL6337448

SCHEMBL6337448

N#C[C@@H](O)Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
CTSC P53634 4/20 0.46
CYP1A2 P05177 1/20 0.45
EPHX1 P07099 1/20 0.44
TRPA1 O75762 2/20 0.44
MAOB P27338 1/20 0.43
ALPI P09923 1/20 0.42
PKM P14618 1/20 0.42
PTGS1 P23219 1/20 0.42
XIAP P98170 1/20 0.42
SLC7A5 Q01650 1/20 0.42
SLC6A2 P23975 2/20 0.41
TAAR1 Q96RJ0 2/20 0.41
MAOA P21397 1/20 0.41
SLC6A4 P31645 1/20 0.41
SLC6A3 Q01959 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
CYP2A6 P11509 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL196712 1.00 TSHR (0.46) TSHRCTSCCYP1A2EPHX1TRPA1
SCHEMBL6334251 1.00 TSHR (0.46) TSHRCTSCCYP1A2EPHX1TRPA1
SCHEMBL12704715 0.83 MAOB (0.58) CYP1A2MAOBPTGS1SLC6A2MAOA
SCHEMBL30045268 0.80 ESR1 (0.60) CYP1A2SLC7A5SLC6A2TAAR1
SCHEMBL30420182 0.79 PPARG (0.48) TSHR
SCHEMBL18703964 0.78 SLC6A4 (0.48) CTSCCYP1A2MAOBSLC6A2MAOA
SCHEMBL3997283 0.78 CTSC (0.44) TSHRCTSCSLC6A2SLC6A4SLC6A3
SCHEMBL2163440 0.78 CTSC (0.44) TSHRCTSCSLC6A2SLC6A4SLC6A3
SCHEMBL4323888 0.78 CTSC (0.44) TSHRCTSCSLC6A2SLC6A4SLC6A3
SCHEMBL11575105 0.78 CTSC (0.44) TSHRCTSCCYP1A2EPHX1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6838581-B2 Process for the preparation of enantiomerically pure 3-phenyl-3-hydroxypropylamine COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-01-04 US disclosed
US-20040110985-A1 Process for the preparation of enantiomerically pure 3-phenyl-3-hydroxypropylamine COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110985-A1 Process for the preparation of enantiomerically pure 3-phenyl-3-hydroxypropylamine CYP2D6, ADH1A, TPH1 TSHR 3383/4885CTSC 4411/4885CYP1A2 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.